Navigation Links
Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
Date:2/27/2009

- Data presented today at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium -

MALVERN, Pa., Feb. 27 /PRNewswire/ -- Ascenta Therapeutics announced today positive preliminary results from its Phase II study of AT-101 in combination with docetaxel and prednisone (D/P) in men with docetaxel refractory, castrate resistant prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in Orlando, FL. AT-101, an oral, pan-Bcl-2 inhibitor currently in double-blinded, randomized Phase II clinical trials in both prostate cancer and non-small cell lung cancer, is the lead compound in Ascenta Therapeutics' portfolio of apoptosis-triggering small molecules.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090227/PH75873 )

"This is the first report of several we plan to present this year from a large and growing data set demonstrating the broad therapeutic potential of AT-101," said Mel Sorensen, MD, CEO of Ascenta Therapeutics. "The evidence of resistance reversal from this refractory population supplements the earlier clinical data demonstrating robust activity with the same regimen in docetaxel-naive patients."

Initial findings from the ongoing open-label, multi-center study demonstrates that AT-101 can be administered safely with D/P in these patients. Investigators also observed clinical responses, based on both PSA and RECIST criteria, including four patients with a confirmed PR (partial response, defined as a PSA decline of 50 percent or greater).

"This first look at the data is very encouraging, particularly since all of these patients were truly refractory to docetaxel, having not simply failed to respond but actually experienced disease progression during prior therapy," said James Reeves, MD, principal investigator, Florida Cance
'/>"/>

SOURCE Ascenta Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
2. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
3. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
4. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
5. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
6. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
7. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
8. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
11. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... shares have been approved for listing and trading on the ... ESSA will begin trading on NASDAQ on July 9, 2015.  ... Exchange under the symbol "EPI". As a result ... each of the Company,s outstanding special warrants issued on January ...
(Date:7/2/2015)... , July 2, 2015  Before you head outdoors ... so you can stay safe and healthy. Take steps to ... Infographic http://nyackhospital.org/summersafety Protect Your Skin From ... the sun can increase your risk of skin cancer. To ... as much as possible, especially during midday hours. Wear a ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... MINNEAPOLIS, May 25, 2011 Uroplasty, Inc. (NASDAQ: ... markets innovative proprietary products to treat voiding dysfunctions, today reported ... ended March 31, 2011. Global sales grew 35% ... 31, 2011, compared with $3.0 million in the fourth fiscal ...
... Sutter Health joins more than a dozen nationally-recognized ... – a project that will share comparative data to ... health care costs across the U.S. ... demonstrable improvements in how we deliver health care to ...
Cached Medicine Technology:Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 2Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 3Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 4Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 5Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 6Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 7Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 8Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 9Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 10Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011 11Sutter Health Joins Health Systems Nationwide to Share and Compare Data on Quality, Outcomes and Cost 2Sutter Health Joins Health Systems Nationwide to Share and Compare Data on Quality, Outcomes and Cost 3
(Date:7/3/2015)... ... ... Food Bank will hopefully be getting a large donation of canned food items at ... SC are making it their mission to collect as many canned items as possible. Donations ... the public as well. As part of the canned food drive, these local chiropractors will ...
(Date:7/3/2015)... ... , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod ... . To be held from March 4th - 6th, the 2016 (a previous announcement ... Dallas. , Designed to take participants from the basic training and fundamentals of nasal ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Talcum powder ... to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the previous ... powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. The ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness ... where they provide members of the Red Deer community with free fitness training and ... fitness training, games, food, events and entertainment raised thousands of charity dollars and ended ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on ... American society right now," Becic said. "We must understand the magnitude of this discovery. ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... Researchers at Washington University School of Medicine in St. ... the National Cancer Institute (NCI) to study the relationship ... fund the Transdisciplinary Research on Energetics and Cancer (TREC) ... diet, weight, physical activity and the environment on cancer ...
... Joint Research Centre has developed three new methods to ... in sports drinks imported from Taiwan. In ... that significant amounts of phthalates were illegally added to ... to affect reproductive performance and fertility, and have been ...
... HealthDay Reporter , THURSDAY, July 28 (HealthDay News) ... years after a breast cancer diagnosis were nearly 40 percent ... lasted for more than a decade after they stopped taking ... results of about 20 randomized controlled trials on a five-year ...
... New research focusing on high-frequency oscillations, termed ripples ... may provide an important marker for the localization ... According to the study now available in ... Against Epilepsy (ILAE), the resection of brain regions ...
... HealthDay Reporter , THURSDAY, July 28 (HealthDay News) -- ... it,s also a time when high temperatures can take a ... for Disease Control and Prevention (CDC) say that from 2001 ... rooms for heat-related illness caused while playing sports or engaged ...
... HealthDay Reporter , THURSDAY, July 28 (HealthDay News) -- ... to pick up speed so that the nation will shell out ... And an increasing amount of that bill -- almost half ... care spending dipped to a "historic low" of 3.9 percent in ...
Cached Medicine News:Health News:WU studies obesity, cancer link with $9.2 million grant 2Health News:JRC develops new testing methods for contaminated sports drinks from Taiwan 2Health News:Tamoxifen Wards Off Breast Cancer's Return for More Than a Decade 2Health News:Tamoxifen Wards Off Breast Cancer's Return for More Than a Decade 3Health News:Fast ripples confirmed to be valuable biomarker of area responsible for seizure activity in children 2Health News:Heat-Linked Illnesses Strike Thousands Each Year: Report 2Health News:Heat-Linked Illnesses Strike Thousands Each Year: Report 3Health News:U.S. to Pay Bigger Share of Rising Cost of Health Care 2Health News:U.S. to Pay Bigger Share of Rising Cost of Health Care 3
For the measurement of vaginal pH as part of a self examination programme to help reduce the risk of pre-term birth...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: